Related Experiment Video
Updated: May 30, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules
Tim Luker1, Lilian Alcaraz, Kamaldeep K Chohan
1AstraZeneca R&D, Medicinal Chemistry, Charnwood, Loughborough, Leicestershire LE11 5RH, UK. Tim.Luker@astrazeneca.com
Abstract:
A valid PLS-DA model to predict attrition in pre-clinical toxicology for basic oral candidate drugs was built. A combination of aromatic/aliphatic balance, flatness, charge distribution and size descriptors helped predict the successful progression of compounds through a wide range of toxicity testing. Eighty percent of an independent test set of marketed post-2000 basic drugs could be successfully classified using the model, indicating useful forward predictivity. The themes within this work provide additional guidance for medicinal design chemists and complement other literature property guidelines.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Toxicity Testing in Animals
Preclinical Development: Overview
Toxicokinetics: Overview
Drug Biotransformation: Overview
Drug Biotransformation: Overview

